CMR Institute Offers New Cardiovascular Specialty Certificate
Program prepares biopharmaceutical representatives to be knowledgeable partners with physicians
in the effort to stem the toll of cardiovascular disease.
CMR Institute Roanoke, Virginia (March 22, 2012) – CMR Institute, the leading provider of non-branded education for biopharmaceutical representatives and managers, announced today that it has launched its new Cardiovascular Specialty Certificate. The program is the first fully online and interactive certificate program designed to provide specialized cardiovascular health education to biopharmaceutical representatives.
CMR Institute’s specialty certificate program is designed to meet biopharmaceutical representatives’ growing need for specialization.
“Overall, our research consistently shows that clinicians expect representatives to understand their products in the framework of real clinical issues,” says Michelle O’Connor, President and Chief Executive Officer, CMR Institute. “This requires evidence-based product information as well as an understanding of total patient management.”
“CMR Institute’s unique cardiovascular program addresses the needs of today’s representatives in a way that enables them to interact knowledgeably with providers about cardiovascular health, disease, and treatment options,” said Gregory Freeman, MD, Director, Division of Cardiology, Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX. “Not only will representatives enhance their value in the field, but they become true partners in the battle against the nation’s most pressing health issue.”
Thus the Cardiovascular Specialty Certificate program was designed to provide representatives with a deeper and wide-ranging understanding of cardiovascular health and disease. The goal of the program is to enable representatives to bring more value to physicians in their fight against heart disease. The 31 module, nine-credit program covers topics including:
- Cardiovascular anatomy and physiology
- The value of nutrition in cardiovascular health
- Cardiovascular risk factors
- An overview of cardiovascular disorders
While the program discusses the role of pharmacology in treatment, it also addresses surgical interventions and the use of catheterization procedures in diagnosis and treatment. Representatives are also guided in how to use this knowledge to succeed in a competitive formulary-driven environment through an evidence-based selling approach.
CMR Institute is the leading independent provider of non-branded education for the pharmaceutical, biotech, and medical device industries and has educated more than 150,000 professionals. Founded in 1966 by physicians in response to a need for increased therapeutic knowledge through scientific education, CMR Institute’s expert content is developed and updated by leading industry experts and distinguished thought leaders. CMR Institute’s not-for-profit status allows it to continually invest its resources in its library of education to realize its mission, which is to advance knowledge to enhance healthcare. To learn more about CMR Institute, visit www.cmrinstitute.org.